Lunai Bioworks Inc. SEC filings LNAI

Lunai Bioworks Inc. has 599 filings in SEC EDGAR's recent list, going back to Aug 12, 2011. Its latest annual report, Form 10-K, was filed on Oct 13, 2026 for the period ended Jun 30, 2026. The latest quarterly report (Form 10-Q) was filed on May 15, 2026, covering the quarter ended Mar 31, 2026. The most recent current report (Form 8-K) was filed on Oct 23, 2026 (listing notice, officer or director change, regulation fd disclosure, other events). The company's fiscal year ends on June 30.

Form Description Filed Period
10-Q Quarterly report May 15, 2026 Mar 31, 2026
10-Q Quarterly report Feb 17, 2026 Dec 31, 2025
10-Q Quarterly report Nov 14, 2025 Sep 30, 2025
10-Q Quarterly report May 15, 2025 Mar 31, 2025
10-Q Quarterly report Feb 19, 2025 Dec 31, 2024
10-Q/A Amended quarterly report Feb 19, 2025 Sep 30, 2024
10-Q/A Amended quarterly report Feb 19, 2025 Mar 31, 2024
10-Q Quarterly report Nov 14, 2024 Sep 30, 2024
10-Q/A Amended quarterly report Aug 20, 2024 Mar 31, 2024
10-Q Quarterly report May 15, 2024 Mar 31, 2024
10-Q Quarterly report Feb 14, 2024 Dec 31, 2023
10-Q Quarterly report Nov 14, 2023 Sep 30, 2023
10-Q Quarterly report May 12, 2023 Mar 31, 2023
10-Q Quarterly report Mar 9, 2023 Dec 31, 2022
10-Q Quarterly report Mar 7, 2023 Sep 30, 2022
10-Q Quarterly report May 13, 2022 Mar 31, 2022
10-Q Quarterly report Feb 14, 2022 Dec 31, 2021
10-Q Quarterly report Nov 15, 2021 Sep 30, 2021
10-Q Quarterly report May 17, 2021 Mar 31, 2021
10-Q Quarterly report Feb 16, 2021 Dec 31, 2020
10-Q Quarterly report Nov 12, 2020 Sep 30, 2020
10-Q Quarterly report May 11, 2020 Mar 31, 2020
10-Q Quarterly report Feb 10, 2020 Dec 31, 2019
10-Q Quarterly report Nov 13, 2019 Sep 30, 2019
10-Q Quarterly report May 16, 2019 Mar 31, 2019
10-Q Quarterly report Feb 13, 2019 Dec 31, 2018
10-Q Quarterly report Nov 14, 2018 Sep 30, 2018
10-Q Quarterly report May 15, 2018 Mar 31, 2018
10-Q Quarterly report Feb 9, 2018 Dec 31, 2017
10-Q Quarterly report Nov 20, 2017 Sep 30, 2017
10-Q Quarterly report May 15, 2017 Mar 31, 2017
10-Q Quarterly report Feb 14, 2017 Dec 31, 2016
10-Q Quarterly report Nov 14, 2016 Sep 30, 2016
10-Q Quarterly report May 13, 2016 Mar 31, 2016
10-Q Quarterly report Feb 12, 2016 Dec 31, 2015
10-Q Quarterly report Nov 13, 2015 Sep 30, 2015
10-Q Quarterly report May 13, 2015 Mar 31, 2015
10-Q Quarterly report Nov 13, 2014 Sep 30, 2014
10-Q Quarterly report Aug 14, 2014 Jun 30, 2014
10-Q Quarterly report May 14, 2014 Mar 31, 2014
10-Q Quarterly report Feb 11, 2014 Dec 31, 2013
10-Q Quarterly report Nov 15, 2013 Sep 30, 2013
10-Q Quarterly report Aug 14, 2013 Jun 30, 2013
10-Q Quarterly report Feb 14, 2013 Dec 31, 2012
10-Q Quarterly report Nov 14, 2012 Sep 30, 2012
10-Q Quarterly report Aug 20, 2012 Jun 30, 2012
10-Q Quarterly report Feb 21, 2012 Dec 31, 2011
10-Q Quarterly report Nov 25, 2011 Sep 30, 2011

Showing 48 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
LNAI (Nasdaq)
Fiscal year ends
June 30
Incorporated in
DE
Headquarters
Suite 906 Los Angeles, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1527728
Former names
RENOVARO INC. (until Aug 26, 2025); RENOVARO BIOSCIENCES INC. (until Feb 7, 2024); Enochian Biosciences Inc (until Aug 1, 2023); DanDrit Biotech USA, Inc. (until Feb 23, 2018); Putnam Hills Corp. (until Feb 11, 2014)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.